James C. Lanter;Nalin Subasinghe;Thomas P. Markotan;Zhihua Sui
发明人:
James C. Lanter,Thomas P. Markotan,Nalin Subasinghe,Zhihua Sui
申请号：
US13161572
公开号：
US08518969B2
申请日:
2011.06.16
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention comprises compounds of Formula I.wherein: R1, R2, R4, J, Q, and A are as defined in the specification. The invention also comprises a method of preventing, treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is type II diabetes, obesity and asthma. The invention also comprises a method of inhibiting CCR2 activity in a mammal by administration of a therapeutically effective amount of at least one compound of Formula I.
